Abstract
Monitoring Prostate Cancer Treatment Response to Radiation Therapy and Androgen Deprivation With Novel Radiolabeled and Dual-Labeled Gastrin-Releasing Peptide Receptor (GRPr) Antagonists
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have